Apply for funding
Cure Parkinson’s funds both preclinical and clinical research projects that have the potential to cure Parkinson’s.
By “cure”, we mean “disease-modifying” therapies that potentially slow, stop or reverse the disease progression of Parkinson’s. In addition, we prioritise research which has the potential to translate into the clinic within five years.
Our Director of Research Dr Simon Stott explains this in more detail in the video below.
Our funding programmes
Quarterly Research Grant Funding Programme
This programme primarily funds preclinical and clinical research focused on disease modification to slow, stop, or reverse Parkinson’s. For preclinical research, projects that could lead to clinical trials in Parkinson’s within 5 years are prioritised. We only fund clinical research in people with Parkinson’s.
iLCT Pipeline Research Acceleration Programme
This programme funds research that has been outlined by our international Linked Clinical Trials (iLCT) committee to be necessary before a therapy can move into clinical trials for Parkinson’s. Depending on the therapy, this may be pre-clinical, epidemiological, dose finding or target engagement research.
